Search results
Results from the WOW.Com Content Network
Guideline Population Goal blood pressure (mmHg) Initial treatment options ESC 2024 [2] General 120–129/70–79 BP >140/90: Two from different classes: preferably RAS-inhibitor (ACEI or ARB) with either thiazide diuretic/thiazide-like diuretic or dihydropyridine CCB. ESH 2023 [3] General age <65 General age 65–79 General age ≥80 <130/80 ...
Guidelines for treating resistant hypertension have been published in the UK [45] and US. [46] It has been proposed that a proportion of resistant hypertension may be the result of chronic high activity of the autonomic nervous system, known as "neurogenic hypertension". [47] Low adherence to treatment is an important cause of resistant ...
It was established in 1985 as the Journal of Clinical Hypertension, obtaining its current name in 1988. [2] [3] It was originally published quarterly by Elsevier, [2] which transferred it to Nature Publishing Group beginning in 2008, [4] [5] but the journal is now published monthly by Oxford University Press, [3] which acquired the journal in 2012.
As of August 2024, 177 programs across 33 states and the District of Columbia are in operation, allowing aging people to stay within their home communities while still receiving the elevated care ...
Claudia Sheinbaum, the presidential candidate of the ruling MORENA party, reacts as she addresses her supporters after winning the election, in Mexico City, on June 3, 2024. / Credit: Raquel Cunha ...
Prehypertension is now referred to as "elevated blood pressure" by the American College of Cardiology (ACC) and the American Heart Association (AHA). [2] The ACC/AHA define elevated blood pressure as readings with a systolic pressure from 120 to 129 mm Hg and a diastolic pressure under 80 mm Hg, [3] Readings greater than or equal to 130/80 mm ...
This year, international migration accounted for 84% of the population growth between 2023 and 2024, with 2.8 million people moving to the U.S. both legally and illegally. The bureau said the ...
Hypertension is a monthly peer-reviewed scientific journal [1] that was established in 1979. It is published on behalf of the American Heart Association by Lippincott Williams & Wilkins . The editor-in-chief is Rhian M. Touyz.